Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The impact of residential change and housing stability on recidivism: pilot results from the Maryland Opportunities through Vouchers Experiment (MOVE).

Kirk DS, Barnes GC, Hyatt JM, Kearley BW.

J Exp Criminol. 2018;14(2):213-226. doi: 10.1007/s11292-017-9317-z. Epub 2017 Dec 15.

2.

Effect of continuing care for people with cocaine dependence on criminal justice sentences.

Wimberly AS, Hyatt JM, McKay JR.

Behav Sci Law. 2018 Jan;36(1):116-129. doi: 10.1002/bsl.2330.

3.

Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence.

Wang AL, Elman I, Lowen SB, Blady SJ, Lynch KG, Hyatt JM, O'Brien CP, Langleben DD.

Transl Psychiatry. 2015 Mar 17;5:e531. doi: 10.1038/tp.2015.20.

4.
6.

Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance.

Hyatt JM, Schentag JJ.

Infect Control Hosp Epidemiol. 2000 Jan;21(1 Suppl):S18-21. Review.

PMID:
10654631
7.

Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa.

Hyatt JM, Schentag JJ.

Infect Control Hosp Epidemiol. 2000 Jan;21(1 Suppl):S9-11.

PMID:
10654629
9.

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy.

Thomas JK, Forrest A, Bhavnani SM, Hyatt JM, Cheng A, Ballow CH, Schentag JJ.

Antimicrob Agents Chemother. 1998 Mar;42(3):521-7.

10.

In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.

Schentag JJ, Birmingham MC, Paladino JA, Carr JR, Hyatt JM, Forrest A, Zimmer GS, Adelman MH, Cumbo TJ.

Semin Respir Infect. 1997 Dec;12(4):278-93. Review.

PMID:
9436955
11.

Modeling the response of pneumonia to antimicrobial therapy.

Hyatt JM, Luzier AB, Forrest A, Ballow CH, Schentag JJ.

Antimicrob Agents Chemother. 1997 Jun;41(6):1269-74.

12.

Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.

Nix DE, Symonds WT, Hyatt JM, Wilton JH, Teal MA, Reidenberg P, Affrime MB.

Pharmacotherapy. 1997 Jan-Feb;17(1):121-5.

PMID:
9017772
14.

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.

Hyatt JM, McKinnon PS, Zimmer GS, Schentag JJ.

Clin Pharmacokinet. 1995 Feb;28(2):143-60. Review.

PMID:
7736689

Supplemental Content

Loading ...
Support Center